Literature DB >> 34244615

Optimizing respiratory management in preterm infants: a review of adjuvant pharmacotherapies.

Jenny K Koo1,2, Robin Steinhorn3,4, Anup C Katheria5,6.   

Abstract

Adjuvant respiratory therapies in preterm neonates aim to reduce long-term morbidities and mortality. Commonly utilized therapies include caffeine, systemic glucocorticosteroids, inhaled steroids, inhaled bronchodilators, and diuretics. This review discusses the available literature that supports some of these practices and points out where clinical practices are not corroborated by evidence. Therapies with no proven clinical benefit must be weighed against potential adverse effects.
© 2021. The Author(s), under exclusive licence to Springer Nature America, Inc.

Entities:  

Year:  2021        PMID： 34244615     DOI： 10.1038/s41372-021-01139-x

Source DB:  PubMed          Journal:  J Perinatol        ISSN： 0743-8346            Impact factor:   2.521


  94 in total

1.  Trend in mortality from respiratory distress syndrome in the United States, 1970-1995.

Authors:  K s Lee; B Khoshnood; S N Wall; Y p Chang; H L Hsieh; J K Singh
Journal:  J Pediatr       Date:  1999-04       Impact factor: 4.406

2.  Association of antenatal corticosteroids with mortality and neurodevelopmental outcomes among infants born at 22 to 25 weeks' gestation.

Authors:  Waldemar A Carlo; Scott A McDonald; Avroy A Fanaroff; Betty R Vohr; Barbara J Stoll; Richard A Ehrenkranz; William W Andrews; Dennis Wallace; Abhik Das; Edward F Bell; Michele C Walsh; Abbot R Laptook; Seetha Shankaran; Brenda B Poindexter; Ellen C Hale; Nancy S Newman; Alexis S Davis; Kurt Schibler; Kathleen A Kennedy; Pablo J Sánchez; Krisa P Van Meurs; Ronald N Goldberg; Kristi L Watterberg; Roger G Faix; Ivan D Frantz; Rosemary D Higgins
Journal:  JAMA       Date:  2011-12-07       Impact factor: 56.272

Review 3.  History of surfactant from 1980.

Authors:  Henry L Halliday
Journal:  Biol Neonate       Date:  2005-06-01

Review 4.  Respiratory distress in the newborn.

Authors:  Suzanne Reuter; Chuanpit Moser; Michelle Baack
Journal:  Pediatr Rev       Date:  2014-10

5.  A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants.

Authors:  G C Liggins; R N Howie
Journal:  Pediatrics       Date:  1972-10       Impact factor: 7.124

Review 6.  Association of Noninvasive Ventilation Strategies With Mortality and Bronchopulmonary Dysplasia Among Preterm Infants: A Systematic Review and Meta-analysis.

Authors:  Tetsuya Isayama; Hiroko Iwami; Sarah McDonald; Joseph Beyene
Journal:  JAMA       Date:  2016-08-09       Impact factor: 56.272

Review 7.  Cognitive Outcomes of Children Born Extremely or Very Preterm Since the 1990s and Associated Risk Factors: A Meta-analysis and Meta-regression.

Authors:  E Sabrina Twilhaar; Rebecca M Wade; Jorrit F de Kieviet; Johannes B van Goudoever; Ruurd M van Elburg; Jaap Oosterlaan
Journal:  JAMA Pediatr       Date:  2018-04-01       Impact factor: 16.193

8.  Respiratory distress syndrome in preterm infants and risk of epilepsy in a Danish cohort.

Authors:  Sandra Kruchov Thygesen; Morten Olsen; Lars Pedersen; Victor W Henderson; John Rosendahl Østergaard; Henrik Toft Sørensen
Journal:  Eur J Epidemiol       Date:  2017-09-08       Impact factor: 8.082

9.  Trends in epidemiology and outcomes of respiratory distress syndrome in the United States.

Authors:  Keyur Donda; Nandini Vijayakanthi; Fredrick Dapaah-Siakwan; Parth Bhatt; Deepa Rastogi; Shantanu Rastogi
Journal:  Pediatr Pulmonol       Date:  2019-01-20

10.  Respiratory distress syndrome in moderately late and late preterm infants and risk of cerebral palsy: a population-based cohort study.

Authors:  Sandra Kruchov Thygesen; Morten Olsen; John R Østergaard; Henrik Toft Sørensen
Journal:  BMJ Open       Date:  2016-10-11       Impact factor: 2.692
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.